The Significance of VEGF Expression in Stage II Carcinoma of Uterine Cervix Treated with Definitive Radiotherapy
![]() |
Park Won
(Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi Yoon-La (Department of Pathology, Samsung Medical Center, Sungkyunkwan Univesity School of Medicine) Huh Seung-Jae (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Yoon Sang-Min (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park Young-Je (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Nam Hee-Rim (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Ahn Yong-Chan (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lim Do-Hoon (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park Hee-Chul (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Huh SJ. Kim BK, Lim DH, et al. Treatment results of radical radiotherapy in uterine cervix cancer. J Korean Soc Ther Radiol Oncol 2002;20:237-245 |
2 | Fyles AW, Milosevic M. Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48: 149-156 DOI ScienceOn |
3 | Inoue K, Ozeki Y, Suganuma T, Susiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997;79:206-213 DOI ScienceOn |
4 | West CM. Davidson SE, Burt PA. Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. lnt J Radiat Oncol Biol Phys 1995;31:841-846 DOI ScienceOn |
5 | Bachtiary B, Selzer E, Knocke TH, Potter R, Obermair A. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett 2002;179:197-203 DOI ScienceOn |
6 | Hockel M. Knoop C. Schlenger K, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50 DOI ScienceOn |
7 | Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309 DOI |
8 | Kodama J, Seki N, Tokumo K, et al. Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur J Cancer 1999;35:485-489 DOI ScienceOn |
9 | Yamamoto S, Konishi I, Mandai M, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 1997;76:1221-1227 DOI ScienceOn |
10 | Hockel M. Schlenger K, Aral B. Mitze M. Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515 |
11 | Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 2005;103:724-730 DOI ScienceOn |
12 | Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-906 DOI ScienceOn |
13 | Lee IJ, Park KR, Lee KK, et al. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2002:54:768-779 DOI ScienceOn |
14 | Cheng WF, Chen CA, Lee CN, Chen TM, Hsieh FJ, Hsieh CY. Vascular endothelial growth factor in cervical carcinoma. Obstet Gynecol 1999;93:761-765 DOI ScienceOn |
15 | Hashimoto I. Kodama J, Seki N, et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 2001;85:93-97 DOI ScienceOn |
16 | 2002 Annual Report of the Korea Central Cancer Registry, Korea Central Cancer Registry |
17 | Ishigami SI. Arii S, Furutani M, et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 1998;78:1379-1384 DOI ScienceOn |
18 | Linderholm B, Tavelin B, Grankvist K, Henriksson R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 1998;16:3121-3128 DOI |
19 | Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-772 DOI ScienceOn |
20 | Terlikowski S, Lenczewski A, Sulkowska M, Famulski W, Sulkowski S, Kulikowski M. Tissue expression of VEGF as a prognostic factor in early cervical squamous cell carcinoma. Folia Histochem Cytobiol 2001;39(Suppl 2):112-113 |
21 | Fontanini G, Boldrini L, Chine S, et al. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. Br J Cancer 1999;79:363-369 DOI |
22 | Kang JO, Hong SE. The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone. J Korean Med Sci 2004;19:693-697 DOI ScienceOn |
23 | Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;36:127-137 DOI |
24 | Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer 2000;83:620-625 DOI ScienceOn |
25 | Cheng WF, Chen CA. Lee CN, Wei LH, Hsieh FJ, Hsieh CY. Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol 2000;96:721-726 DOI ScienceOn |
26 | Gupta VK, Jaskowiak NT, Beckett MA. et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J 2002;8:47-54 DOI |
![]() |